Allelica

Allelica is a pioneering company in the field of genomic medicine, specializing in the development and commercialization of polygenic risk scores (PRS) for clinical use. The company primarily serves health systems and clinical laboratories, providing them with advanced tools to assess genetic risk factors for chronic diseases such as cardiovascular conditions. Operating in the precision medicine market, Allelica leverages cutting-edge genomic research to create actionable insights for disease prevention and management.

The business model is centered around the commercialization of its proprietary PRS technology, which is integrated into healthcare systems to enable more effective primary prevention strategies. Revenue is generated through the sale of these genomic tools and services to healthcare providers and laboratories, as well as through collaborations with pharmaceutical companies and research institutions.

Allelica's core product, CardioriskSCORE, has been developed in collaboration with leading cardiovascular scientific societies and has been published in reputable medical journals. The company is recognized for its contributions to the field, having been selected by the American Society of Human Genetics as one of the top 10% of abstracts presented at their virtual meeting.

Keywords: Genomic medicine, polygenic risk scores, chronic disease prevention, precision medicine, cardiovascular risk, healthcare systems, clinical laboratories, genetic risk assessment, CardioriskSCORE, pharmaceutical collaborations.